Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04920474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

StatusRecruiting
PhaseNot specified
Started1991-07
View on ClinicalTrials.gov ↗

Amendment history

2023-05-01
Study Status v1
Primary completion date2025-07→2030-07
Completion date2025-07→2030-07
2021-06-03
Original filing
The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy. Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including: * investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data * evaluating the factors that affect transplant or cellular therapy outcome * studying the distribution of HLA tissue types in different populations * studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries * performing de-linked (anonymous) research
Trial Details
NCT Number NCT04920474
Lead Sponsor Center for International Blood and Marrow Transplant Research
Conditions Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Cellular Therapy, Marrow Toxic Injury
Enrollment 99,999,999 participants
Start Date 1991-07
Primary Completion 2030-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2023-05-03